Zdrowie i gospodarka · 14/02/1996

FDA Proposes New Warning Labeling for Over-the-Counter Phenylpropanolamine Products

The Food and Drug Administration (FDA) is proposing new labeling requirements for all over-the-counter (OTC) medications containing phenylpropanolamine, a sympathomimetic drug used in weight control, cough-cold, and allergy products, to advise consumers of potential risks when taking these medications with other sympathomimetic drugs.